
When French pharmaceutical company Sanofi announced the appointment of Dr Anne Beal as chief patient officer in late March, the …

Amersham-based UK medical education company Wave has appointed three new members of staff. Charlotte Wilkinson joins as programme manager and …

Biogen Idec is celebrating after the Committee for Medicinal Products for Human Use (CHMP) gave its multiple sclerosis drug Plegridy …
Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …

The use of ‘extravagant’ dinners and ‘excessive alcohol’ has landed Merck Serono in hot water with the PMCPA as it’s …

Creative agency PAN has reinforced its account handling and planning teams with two new arrivals and three promotions. Aisha Regan …

A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …

Novartis has bought the rights to licence and commercialise a novel anti-PGDF therapy which it is currently trialling in Phase …

The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …
The ABPI has appointed David Watson as its new head of Commercial, who will be reporting to the association’s Commercial …

Animals should not be used for Alzheimer’s research according to a new paper, because scientists should instead be looking at …

Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …

Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …

Publicis Healthcare-owned med comms firm Medicus International has been rebranded as Discovery London. Barbara Joly is the general manager of …
The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …
Publicis Healthcare-owned medical communications group Medicus International has rebranded to Discovery London, thereby officially joining the Discovery worldwide brand. Discovery …